Cystic Fibrosis Clinical Trials Database - Free Access to 1,078 Studies
Access comprehensive clinical trial information for Cystic Fibrosis through Pure Global AI's free database. This collection includes 1,078 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 140 trials are actively recruiting participants.
Research for Cystic Fibrosis is being conducted in United States of America, France, United Kingdom and 7+ other countries. Leading sponsors include Vertex Pharmaceuticals Incorporated and Assistance Publique - H么pitaux de Paris. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
A study comparing Tobramycin Inhalation Powder (TIP) administered once daily continuously versus TIP administered BID in 28 day on / 28 day off cycles for the treatment of pulmonary Pseudomonas aeruginosa in patients with cystic fibrosis
A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis
A Study of the effects of Lumacaftor/Ivacaftor Treatment in Subjects
A study in people with cystic fibrosis (a rare pulmonary disease) to assess the pharmacokinetics and safety of a combination of two experimental drugs"
A Study to Evaluate the Effect of VX-661 in Combination With Ivacaftor on Chest Imaging Endpoints in Subjects With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung Disease
Study of VX-770 in Cystic Fibrosis Subjects Age 12 and Older Homozygous for the F508del-CFTR Mutation
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C->T or D1152H CFTR Mutation
Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.
Pathogenicity of Species of the Achromobacter Genus in Patients From Reunion Island With Cystic Fibrosis
Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study
Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment
A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet Formulation
Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
CFTR Modulators in Pregnancy and Postpartum
e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
Pure Global AI provides free access to 1,078 clinical trials studying Cystic Fibrosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Vertex Pharmaceuticals Incorporated, Assistance Publique - H么pitaux de Paris, Hospices Civils de Lyon, among others.